Yes, Emend Treats Chemotherapy-Induced Nausea
Emend (fosaprepitant dimeglumine for injection or aprepitant oral capsules) is FDA-approved to prevent nausea and vomiting caused by chemotherapy, especially with highly emetogenic (vomit-inducing) drugs like cisplatin.[1] It's given as part of a multi-drug regimen, often with steroids like dexamethasone and 5-HT3 blockers like ondansetron, typically starting before chemo infusion.
How Emend Fits into Chemo Protocols
Emend targets substance P/neurokinin-1 (NK1) receptors in the brain to block delayed nausea, which hits 24-120 hours post-chemo. A single IV dose of 150 mg fosaprepitant on day 1 covers up to 4 days, or oral aprepitant is dosed 125 mg day 1, 80 mg days 2-3.[1] Guidelines from ASCO and NCCN recommend it for moderate-to-high emetogenic chemo.
Who Makes Emend and What's the Cost
Merck & Co. manufactures Emend. A single IV vial runs $600-$800 without insurance; oral packs cost $500-$700 for a course.[2] Patient assistance programs from Merck can reduce costs for eligible users.
When Does Emend's Patent Expire
Key U.S. patents on aprepitant expired in 2026, with pediatric exclusivity ending May 2026. Generic entries began appearing in Europe earlier; U.S. generics like those from MSN and Aurobindo launched post-2023 settlements.[3] Check DrugPatentWatch.com for latest litigation and Paragraph IV challenges.
Common Side Effects Patients Report
Fatigue, diarrhea, hiccups, and constipation affect 10-20% of users. Serious risks include allergic reactions or liver issues (rare, <1%). It's contraindicated with pimozide or strong CYP3A4 inhibitors like ketoconazole.[1]
Alternatives to Emend for Chemo Nausea
| Drug | Mechanism | Typical Use | Notes |
|------|-----------|-------------|-------|
| Akynzeo (netupitant/palonosetron) | NK1 + 5-HT3 | Single oral dose | Fixed combo, similar efficacy[1] |
| Varubi (rolapitant) | NK1 | IV/oral, lasts 5 days | Avoid with rifampin[1] |
| Sustol (granisetron ER) | 5-HT3 extended-release | High emetogenic chemo | Injection every 2 weeks max |
| Generic aprepitant | Same as Emend | Post-patent | 30-70% cheaper[3] |
Can You Use Emend for Non-Chemo Nausea
No, it's not approved for postoperative nausea, radiation, or general motion sickness—efficacy data lacks support there.[1] Off-label use happens rarely but isn't guideline-backed.
[1]: FDA Label for Emend
[2]: GoodRx Pricing Data
[3]: DrugPatentWatch.com - Emend